Cassava Sciences, Inc.
(NASDAQ: SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

1.955 -

-0.035 (-1.76%)
价格区间 1.950 - 2.030   (4.10%)
开盘 1.970
昨收 1.990
买 -
买盘 -
卖 -
卖盘 -
成交量 258,479
成交额 3,509,459
注释 -
数据延迟。最后一次更新17 Mar 2026 03:59.
数据提供商
查看所有活动
Please login to view stock data and analysis